antagonism of neuromuscular block using cholinesterase inhibitors and atropine is charged with several risks , which are at least partly caused by pharmacological characteristics of the anticholinergic drugs , e.g . short duration of action causing secondary bradycardia .
C0004259
atropine
C0428977
bradycardia